# Cumberland Pharmaceuticals Inc: Form 8-K, filed Mar 9, 2018

- Company: [Cumberland Pharmaceuticals Inc](/companies/cpix.md) (CIK 1087294)
- Form: 8-K
- Filed: 2018-03-09
- Accepted by EDGAR: Mar 9, 2018, 16:55 ET
- Period: 2018-03-09
- Accession: 0001628280-18-003033
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1087294/000162828018003033/a2017q4-earningsrelease.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1087294/000162828018003033/

## Items reported

- Item 2.02: Results of operations

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1087294/000162828018003033/a2017q4-earningsrelease.htm

Filed Mar 9, 2018.
Source: SEC EDGAR, the filing index for accession 0001628280-18-003033. Last ingested by Listed: Nov 11, 2026, 03:05 ET. No prices; not investment advice.